Strides Pharma posts Rs 140 crore profit before tax for September quarter

Riding on strong growth from regulated markets, pharmaceutical major Strides Pharma Science posted robust profit-before-tax (PBT) of Rs 140.43 crore for the second quarter ended September 30. It had posted a loss of Rs 10.80 crore in the corresponding period of the previous fiscal.

The firm reported a net profit of Rs 141.91 crore for Q2. It had posted a loss of Rs 8.70 crore for the corresponding period of FY19. “This quarter’s financial results validate our reset strategy, with enhanced focus on growth and margin opportunities from regulated markets,” said Arun Kumar, group chief executive officer and managing director, Strides